Silver Book Fact

Between 1988 & 1994 and 1999 & 2004, use of pharmacological lipid-lowering treatment increased from 11.7% to 40.8%. Low-density lipoprotein cholesterol control increased from 4.0% to 25.1% among those with
high low-density lipoprotein cholesterol.

American Heart Association. Heart Disease and Stroke Statistics- 2008 Update. Circulation. 2008; 117. http://circ.ahajournals.org/cgi/content/short/117/4/e25

Reference

Title
Heart Disease and Stroke Statistics- 2008 Update
Publication
Circulation
Publication Date
2008
Authors
American Heart Association
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Increased use of non-acute medications in primary and secondary prevention explains about 1/3 of the total reduction in cardiovascular disease mortality since 1950.  
  • TAVR Success in sSAS Patients
    A study of severe symptomatic aortic stenosis (sSAS) patients who received transcatheter aortic valve replacement (TAVR) found 30-day mortality of 2.2% for those who were high risk of surgical mortality/inoperable,…  
  • The rise in beta-blocker treatment rates (34% since 1996) is proof that sustained attention and effective initiatives saves lives and improves quality of life.  
  • A study exploring the decline in deaths attributable to cardiovascular disease in the U.S. from 1980 to 2000 suggested that approximately 47% of the decrease was due to the increased…  
  • Beta-Blocker Treatment After A Heart Attack: Trends, 1996-2006